It took several years after various publications on the benefits of GLP-1 in humans from different academic labs for pharmaceutical companies, including the above-mentioned Novo Nordisk, to become interested in it
In clinical trials of patients who have type 2 diabetes, hypoglycemia has been reported
However, it should be remembered that marketed products containing monacolin K may differ with respect to dose, which translates into potency
Hormones absorb better
Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, et al
[DOI] [PubMed] [Google Scholar] 153.Grattagliano I., Montezinho L.P., Oliveira P.J., Fruhbeck G., Gomez-Ambrosi J., Montecucco F., Carbone F., Wieckowski M.R., Wang D.Q., Portincasa P